Intraperitoneal administration of interferon-gamma to carcinoma patients enhances expression of tumor-associated glycoprotein-72 and carcinoembryonic antigen on malignant ascites cells

Journal of Clinical Oncology

Volumn 10, Issue 5, 1992, Pages 735-746

  Greiner, J W ^a   Guadagni, F ^a   Goldstein, D ^a   Smalley, R V ^a   Borden, E C ^a   Simpson, J F ^a   Molinolo, A ^a   Schlom, J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; GAMMA INTERFERON; MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY; TUMOR ANTIGEN; TUMOR MARKER;

ANTIBODY AFFINITY; ANTIGEN EXPRESSION; ARTICLE; ASCITES CELL; ASCITES FLUID; CLINICAL ARTICLE; DIAGNOSIS; DIAGNOSTIC ACCURACY; DOSE RESPONSE; FLOW CYTOMETRY; GASTROINTESTINAL CARCINOMA; HUMAN; IMMUNOPEROXIDASE STAINING; INTRAPERITONEAL DRUG ADMINISTRATION; OVARY ADENOCARCINOMA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL;

EID: 0026751575     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1992.10.5.735     Document Type: Article

References (0)